From the strategic update in March 2021.
Personally, I'm very interested to see if Bisantrene inhibits FTO in non-cancerous cells and how that effects the downstream expression of genes and the impact that has on cellular function, because there have been a couple non-cancerous diseases linked to overexpression of FTO. I don't know how much 'low-cost' is, but I believe the cost to reward ratio is worth taking a look at.
- Forums
- ASX - By Stock
- RAC
- Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene
Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene, page-36
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.045(3.01%) |
Mkt cap ! $247.1M |
Open | High | Low | Value | Volume |
$1.50 | $1.52 | $1.45 | $62.74K | 42.47K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14110 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 666 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14110 | 1.450 |
1 | 347 | 1.445 |
1 | 525 | 1.420 |
3 | 14000 | 1.410 |
7 | 19649 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 666 | 1 |
1.500 | 5656 | 2 |
1.520 | 485 | 1 |
1.525 | 11000 | 1 |
1.530 | 10000 | 1 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |